Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score.

about

Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score.

Item

http://www.wikidata.org/entity/Q47126037

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Improving outcome and prognosi ...... using a gene expression score.

@en

Improving outcome and prognosi ...... using a gene expression score.

@nl

type

Item

label

Improving outcome and prognosi ...... using a gene expression score.

@en

Improving outcome and prognosi ...... using a gene expression score.

@nl

prefLabel

Improving outcome and prognosi ...... using a gene expression score.

@en

Improving outcome and prognosi ...... using a gene expression score.

@nl

P1476

Improving outcome and prognosi ...... using a gene expression score.

@en

P2093

Johannes Breyer

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular characterization of urothelial bladder carcinoma

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting.

Economic impact of tumor markers in bladder cancer surveillance.

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology.

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.

A molecular taxonomy for urothelial carcinoma.

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.

P304

991-993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/TAU.2017.09.06

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29184802

http://www.w3.org/2001/XMLSchema#string

P932

5673822

http://www.w3.org/2001/XMLSchema#string